Quadruple vs triple therapy for resistant hypertension: the QUADRO trial

20260 citationsJournal Articlehybrid Open Access

Authors

S Taddei · University of Pisa

K Narkiewicz · Gdańsk Medical University

Stéphanie Bricout-Hennel · Institut des Sciences du Végétal

Parvoleta Petrova · Servier (France)

Cécile Batailler · Institut des Sciences du Végétal

Roland Asmar · Medical Research Foundation

Abstract

The first full-dose quadruple antihypertensive SPC (perindopril/indapamide/amlodipine/bisoprolol) demonstrated superiority over perindopril/indapamide/amlodipine, offering an effective alternative therapy for confirmed resistant hypertension.

Topics & Keywords

Blood Pressure and Hypertension Studies Heart rate and cardiovascular health Receptor Mechanisms and Signaling

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Heart Journal

DOI: 10.1093/eurheartj/ehag022

Field-Weighted Citation Impact: 0.00